Article
Dec 08, 2020
Injection Foundations Workshop – Digital On-Demand
Naph Ler
RELATED RESOURCES
Continue exploring related topics.
VIEW ALL
SSRP Institute
Aug 21, 2026
Alpha-Gal Syndrome: An Update on Incidence Rate by the CDC
HEADLINE SCIENCE JAMA recently published a report about the incidence rate of alpha-gal syndrome, which is a serious allergic reaction to a sugar molecule called alpha-gal, which is found in most mammals. It is typically transmitted through a bite from a Lone Star tick or other tick species that injects the molecule into the body, […]
READ NEWS
VIDEO
Cellular Medicine Mondays
Aug 17, 2026
Ep. 101 - Office Hours: PWC26 Virtual Summit Part 3
Preview Only
Office Hours PWC26 Virtual Summit Part 3 – Episode 101
Office Hours PWC26 Virtual Summit Part 3 – Episode 101
1. Mitochondrial peptides (1:07)
2. MOTS-c cycle (3:50)
3. Injury site specific injection (9:25)
4. BPC-157 dosing (15:18)
5. Trusted labs (20:56)
6. What “redox” means (25:48)
7. Patient with cervical fusion, pain, and decreased range of motion (31:36)
8. Lipedema (37:03)
9. SS-31 and MOTS-c (37:52)
10. NanoVI device (44:49)
11. NAD (48:13)
Preview Only — Become a member for full access
IntellxxDNA
Aug 12, 2026
SSRP Institute Welcomes IntellxxDNA as New Trusted Partner
PARTNER ANNOUNCEMENT WILLOUGHBY, Ohio, [August 12, 2026] — The SSRP Institute welcomes IntellxxDNA to its Trusted Partner Network following a nomination and internal vetting process, aligning with SSRP’s mission to advance science-first, education-driven clinical collaboration. IntellxxDNA provides clinicians with a structured genomic decision support platform that translates complex genetic data into clinically actionable insights. Using […]
READ NEWS
VIDEO
Cellular Medicine Mondays
Aug 10, 2026
Ep. 100 - Office Hours: PWC26 Virtual Summit Part 2
Preview Only
Office Hours PWC26 Virtual Summit Part 2 – Episode 100
Office Hours PWC26 Virtual Summit Part 2 – Episode 100
- Evaluating terrain of the patient (1:43)
- SS31 peptide in practice (8:50)
- Phenotyping the right patient for GLP-1 therapy (11:18)
Preview Only — Become a member for full access
William Seeds, MD
Aug 6, 2026
A Lipid at the Root of Mitochondrial Aging: Phosphatidylcholine, Methylation, and a Malleable Therapeutic Window
Mitochondrial dysfunction is one of the most firmly established hallmarks of aging, but the field has spent far more energy describing genetic causes of mitochondrial failure—mtDNA mutation, defective OXPHOS, impaired unfolded protein response—than the “natural” drivers that erode mitochondria during ordinary aging. As I discussed in my recent June Journal Club (as well as a […]
READ ARTICLE
VIDEO
Cellular Medicine Mondays
Aug 3, 2026
Ep. 099 - Office Hours: PWC26 Virtual Summit Part 1
Preview Only
Office Hours: PWC26 Virtual Summit Part 1 – Episode 099
Office Hours: PWC26 Virtual Summit Part 1 – Episode 099
This special edition of Office Hours features questions submitted during the Peptide World Congress Virtual Summit on July 10 and 11. Dr. Seeds and Dr. Newman address:
- GLOW Stack, MOTS c, and Thyroid Function (0:50)
- Should the GLOW Stack Be Separated? (3:31)
- Peptides in Transplant Medicine (8:02)
- Biomarker Monitoring (13:21)
- Peptides in Acute and Long Term Stroke Recovery (17:37)
- Autoimmunity and the GI Tract (23:00)
- Cancer Concerns Related to Hormones and Angiogenesis (26:49)
Preview Only — Become a member for full access
VIDEO
Cellular Medicine Mondays
Jul 27, 2026
Ep. 098 - Pentosan Polysulfate: Dosing, Safety, and Monitoring
Preview Only
Dissecting Protocols – Episode 098
Pentosan Polysulfate: Dosing, Safety, and Monitoring
Dr. Seeds examines the subcutaneous use of pentosan polysulfate, addressing concerns about injection site scarring and ocular safety. He discusses dosing, site rotation, cumulative exposure, retinal screening, and strategies for responsible, individualized treatment.(Question Link)
Preview Only — Become a member for full access
SSRP Institute
Jul 24, 2026
PCAC Meeting Vote Summary
BREAKING NEWS JULY 24, 2026 – The Pharmacy Compounding Advisory Committee (PCAC) has completed its July session, voting on several peptide bulk drug substances for potential inclusion on the FDA’s 503A Bulks List.Recommended FOR inclusion: (Yes-No)• BPC-157 (8–6)• KPV (8–6)• TB-500 (8–6)• MOTS-c (7–5)• Epitalon (7–4)• Semax (8–5)Recommended AGAINST inclusion: (Yes-No)• DSIP (6–7) What happens […]
READ NEWS
VIDEO
Cellular Medicine Mondays
Jul 20, 2026
Ep. 097 - Creatine: Evidence, Pathways, and Hype
Preview Only
Rabbit Holes – Episode 097
Creatine: Evidence, Pathways, and Hype
Dr. Seeds examines creatine through a cellular medicine lens, separating evidence-supported uses in ATP buffering, performance, and methylation from claims that exceed current clinical data.
Preview Only — Become a member for full access
William Seeds, MD
Jul 14, 2026
The Renin–Angiotensin–Aldosterone System (RAAS): Beyond Blood Pressure Regulation
After a recent Journal Club episode in which I featured, The Renin–Angiotensin–Aldosterone System (RAAS): Beyond Cardiovascular Regulation, I wanted to return to the article and expand a bit on the significance of the Renin–Angiotensin–Aldosterone System (RAAS). As we know, the RAAS system has traditionally been viewed as the body’s primary mechanism for regulating blood pressure, […]
READ ARTICLE